Fish oil pills tested for lowering fat levels in overweight chileans

NCT ID NCT06538324

Completed Disease control Sponsor: Universidad San Sebastián Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether low-dose omega-3 supplements (250 mg EPA per day) can improve cholesterol and inflammation in overweight or obese adults with high triglycerides. Forty participants in Chile took omega-3 or a placebo for six weeks each in a crossover design. The goal was to see if this simple dietary change could help control blood fat levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omega-3 fatty acids (EPA) and high-oleic sunflower oil (HOSO) as a placebo
What this could lead to: If it works, this could point toward a simple dietary supplement to help manage high triglycerides in overweight individuals.
What could go wrong: This is a small, completed trial with only 40 participants, so results may not apply broadly. The omega-3 dose is low (250 mg EPA per day), which may not be enough to produce meaningful changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertriglyceridemia Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTRIGLYCERIDEMIA OVERWEIGHT

Contacts and locations

Locations

Universidad San Sebastián

Valdivia, Los Ríos Region, 5090000, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.